Overview
Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee
Status:
Completed
Completed
Trial end date:
2006-03-01
2006-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a phase III, multicentre, randomized, double blind, parallel-group, pilot study designed to compare a long term (12 weeks) versus a short term (2 weeks) treatment with celecoxib 200 mg/die in treatment and prevention of new flare in patients with osteoarthritis of the knee.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
PfizerTreatments:
Celecoxib
Criteria
Inclusion Criteria:- diagnosis of OA of the knee according to the ACR Classification Criteria for
osteoarthritis;
- patients in flare
Exclusion Criteria:
- any concomitant inflammatory rheumatic condition which may interfere with the
assessment of OA
- clinical or radiological evidence of chondrocalcinosis